Zoetis Inc. Reports $2.4B Revenue in Strong Third Quarter 2024 Performance
Zoetis Inc. (NYSE: ZTS) announced robust financial results for the third quarter of 2024, with revenue reaching $2.4 billion.
BTC$63,494.00+1.49%
ETH$1,712.39+1.33%
USDT$0.9991+0.00%
USDC$0.9999+0.01%
XRP$1.14+1.25%
SOL$70.74+3.31%
TRX$0.3222+0.56%
FIGR_HELOC$1.03+2.13%
HYPE$69.50+4.73%
DOGE$0.0833+1.24%
USDS$0.9997-0.01%
RAIN$0.0145+0.07%
LEO$9.59+0.09%
ZEC$470.63+5.81%
XLM$0.213-2.66%
BTC$63,494.00+1.49%
ETH$1,712.39+1.33%
USDT$0.9991+0.00%
USDC$0.9999+0.01%
XRP$1.14+1.25%
SOL$70.74+3.31%
TRX$0.3222+0.56%
FIGR_HELOC$1.03+2.13%
HYPE$69.50+4.73%
DOGE$0.0833+1.24%
USDS$0.9997-0.01%
RAIN$0.0145+0.07%
LEO$9.59+0.09%
ZEC$470.63+5.81%
XLM$0.213-2.66%
Fortis Inc. (TSX/NYSE: FTS) reported strong third-quarter performance, with net earnings of $420 million, or $0.85 per common share, driven by rate base expansion and favorable earnings in Arizona.
Zoetis Inc. (NYSE: ZTS) announced robust financial results for the third quarter of 2024, with revenue reaching $2.4 billion.
FIS reported a 7% increase in GAAP Diluted EPS to $0.45 and a significant 49% rise in adjusted EPS.
Freshpet, Inc. reported a strong third-quarter performance with net sales reaching $253.4 million, marking a 26.3% increase y/y.
Entegris, Inc. reported a 9% decrease in net sales for the third quarter of 2024, with adjusted sales showing a 7% year-over-year increase.
Charter Communications, Inc reported a strong performance in the third quarter of 2024, with a 1.6% increase in total revenue.
Cardinal Health's Q1 FY25 results revealed a 4% decline in total revenue but a 9% improvement in gross margin.
ExxonMobil's third-quarter earnings of $8.6 billion, or $1.92 per diluted share.
Chevron Corporation (NYSE: CVX) reported earnings of $4.5 billion, or $2.48 per diluted share, for the third quarter of 2024.
Uber exceeded Wall Street expectations but slower gross bookings growth puts pressure on stock price.
Eaton Corporation plc has reported record-breaking results for the third quarter of 2024, with an EPS of $2.53 and a third-quarter sales record of $6.3 billion.
Merck's third-quarter financial performance in 2024 showcased robust worldwide sales growth of 4%, reaching $16.7 billion.
The Cigna Group (NYSE: CI) has reported impressive financial results for the third quarter of 2024.